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Abstract
The mucosa of the female reproductive tract plays a pivotal role in host defence. Pregnancy
must alter immunological mechanisms at this interface to protect the conceptus. We sought
to determine how estradiol (E2) alters the immune-responsiveness of cervical epithelial cells
to ligand stimulation of Toll-like receptor (TLR)-2 and -4. Human ectocervical epithelial cells
(HECECs) were cultured and co-incubated with two concentrations of E2 and peptidoglycan
(PGN) or lipopolysaccharide (LPS) over durations that ranged between 10 minutes and 18
hours. Cytometric Bead Array was performed to quantify eight cytokines in the supernatant
fluid. In response to PGN, HECECs co-incubated with E2 released lesser quantities of IL-1ß
and IFNγ, higher levels of RANTES, and variable levels of IL-6 and IL-8 than those not
exposed to E2. In contrast, HECECs co-incubated with LPS and E2 secreted increased levels
of IL-1ß, IL-6, IL-8, and IFNγ at 2 and 18 hours than HECECs not exposed to E2, and reduced
levels of RANTES at same study time-points. Estradiol alters the immune-responsiveness of
cultured HECECs to TLR2 and TLR4 ligands in a complex fashion that appears to vary with
bacterial ligand, TLR subtype, and duration of exposure. Our observations are consistent
with the functional complexity that this mucosal interface requires for its immunological roles.
1. Introduction
The epithelium of the female reproductive tract plays a pivotal role in host defence against
pathogens. It secrets specific mucosal proteins such as mucins and defensins [1,2], and recog-
nises pathogen-associated molecular patterns (PAMPs) on microbes [3,4] through pattern rec-
ognition receptors (PRR) of the Toll-like receptor (TLR) family amongst others [5,6]. The
epithelium also provides a mechanical barrier against microbes, and secretes cytokines and
antimicrobial peptides which coordinate the local innate and adaptive immune responses
[7,8]. There is emerging evidence that these innate immunological mechanisms are altered
during pregnancy in order to provide additional protection to the fetus and other products of
conception, by preventing the ascent of micro-organisms up the reproductive tract [9]. These
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changes may also modulate the inflammatory processes that trigger cervical remodelling (such
as cytokine-mediated synthesis of collagenases and elastases) and the uterine contractions
associated with the onset of labour [9,10].
TLRs can interact with endogenous molecules released from damaged tissues or dead cells.
These molecules are chronic inflammatory biomarkers or damage-associated molecular pat-
terns (DAMPs). They regulate many sterile inflammation processes and recognize and
respond to PAMPs [11,12]. DAMPs comprise High-mobility group box 1 (HMGB1), heat
shock proteins (HSPs), S100 proteins, and distorted matrix proteins and play some role in ini-
tiation and progress of preterm birth (PTB) [11].
Engagement of epithelial TLRs by specific ligands leads to increased expression of mediators
of inflammation, such as cytokines and chemokines, through the activation of transcriptional
factors of the nuclear factor (NF)-κB family [13,14]. Increased elaboration of pro-inflammatory
cytokines especially interleukin (IL)-1β, IL-6, IL-8 and TNF has been demonstrated [15]. There
is emerging evidence that changes in TLR-mediated signalling during pregnancy play key roles
in alterations in immune and inflammatory processes, and may be implicated in premature
birth [15,16]. For instance a variant in the human TLR4 gene has been shown to be associated
with an increased risk for premature birth and the secretion of pro-inflammatory cytokines [17]
especially interleukin (IL)-1β, IL-6, IL-8 and TNF [18]. The release of IL-6 and IL-8 due to LPS
exposure has also been shown to alter ectocervical epithelial barrier functions by increasing per-
meability [19,20].
We have recently observed that the expression of Toll-like receptors (TLR) -2 and -4 in
human cervical tissue is increased during pregnancy [21], also reported in several other tissues
during gestation [22]. However, the underlying mechanism and functional implications of
these observations remain unclear. Hormones have been reported to regulate the function of
several PRRs in some tissues [22,23]. We therefore hypothesised that estradiol (E2), an endoge-
nous gestational hormone, may alter cervical epithelial immune-responsiveness as part of the
required adaptation of reproductive tract tissue to pregnancy. In this study, we detail the
effects of E2 on the cytokine expression profiles (as a marker of epithelial immune responsive-
ness) of cultured human ectocervical epithelial cells coincubated with the ligands of TLR2
(peptidoglycan, PGN) and TLR4 (lipopolysaccharide, LPS).
2. Materials and methods
2.1 Study design
The South Sheffield Research Ethics Committee (SSREC/03/105) granted approval for this
study. Written informed consent from participants was obtained prior to the collection of all
samples.
2.2 Subjects and tissue samples
Human ectocervical tissue was obtained from fresh hysterectomy specimens from 62 premen-
opausal patients (age range 29–50 years) undergoing their operations for benign dysfunctional
uterine bleeding. All subjects had had a negative urinary pregnancy test, a normal cervical
smear within the previous three years, negative swabs for genital infection, and were not taking
hormonal contraceptives at least six weeks before surgery.
2.3 Epithelial Growth Medium (EGM)
Minimum Essential Medium (MEM) D-Valine (C-75100, Promo Cell, UK), supplemented
with heat inactivated fetal bovine serum (FBS) (BioWhittaker, Lonza, Belgium Cat # DE14-
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820F), 0.2 mM L-glutamine, hydrocortisone (Sigma, UK Cat. # H4001) (5ml of stock solution
40 μg/ml), penicillin-streptomycin-Amphotericine B stock (Sigma, Cat # A5955), as described
previously by Kamine et. al. [24], was used for culturing primary HECECs. The most impor-
tant cells that can contaminate such epithelial explant cultures are fibroblasts [24–26]. Substi-
tution of D-valine for L-valine selectively inhibits proliferation of fibroblasts, which lack the
enzyme D-amino acid oxidase that converts the D-amino acid into its essential L-isoform
[24,27]. MEM L-Valine without Phenol Red (Gibco, Cat. No.; 51200) and Charcoal-filtered
FBS (South American origin, Cat. No. DE14-820E, Lonza) were substituted for MEM D-Valine
and FBS respectively three days prior to the co-incubation experiments while hydrocortisone
was omitted at this stage [28].
2.4 Establishment of the primary cell cultures
The tissues were collected by 8mm punch biopsies and were immediately placed in ice-cold
EGM and rinsed several times with 1x phosphate buffered saline (PBS) and EGM. The epithe-
lia were isolated carefully under the microscope, diced into 1–2 mm fragments and were then
subjected to enzymatic digestion using collagenase IV (1 U/ml) (Gibco, Cat. No; 17104–019)
in MEM for one hour at 37˚C on a rotating surface followed by 10 minutes incubation with 1x
trypsin (T3924, Sigma, UK) at 37˚C [24]. The digested tissue clumps were collected and trans-
ferred to six well plates (Greiner Bio-One Ltd, Stonehouse, UK) after deactivating the trypsin.
The tissue fragments were left to dry and adhere to the bottom of the wells for 10 minutes. The
explants were incubated in 2 ml of EGM and maintained in a humidified incubator with 5%
CO2 at 37˚C. The medium was changed every three days. When the outgrowths of cultured
HECECs reached 80% confluence (3–4 weeks), HECECs were employed for functional and
gene expression studies or passaged. Cell Dissociation Solution Non-enzymatic (CDSNE)
(Sigma UK, Cat. No. C5914) was used to remove the cultured cells from the culture plastic
wares.
2.5 Fibroblast cultures
Human Neonatal Foreskin Fibroblasts (HNFF) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% (v/v) fetal calf serum (FCS) and 2 mM L-glutamine.
The HNFFs were kindly provided by Dr. B. Aflatoonian (Academic Unit of Reproduction and
Developmental Medicine, Jessop Wing, University of Sheffield). The HNFF cultures were
maintained in a humidified incubator with 5% CO2 at 37˚C and the medium was changed
every 2–3 days. The cultured HNFFs were used as positive control for CD90 staining.
2.6 Double immuno-fluorescence sequential staining
Primary and/or first passaged cultured HECECs on 8-well chamber slides (Falcon Fisher sci-
entific, 08-774-25) were fixed with acetone (-20˚C) for 10 min at room temperature and per-
meabilised by 0.1% (v/v) Triton X-100 in PBS for 10 min, followed by blocking with 3% (w/v)
bovine serum albumin (BSA) for 30 minutes twice at room temperature. Primary antibodies
against cytokeratin, phycoerythrin conjugated (CK PE) (ab52460, abcam, UK, Anti-pan CK 4,
5, 6, 8, 10, 13, 18) and CD90, FITC conjugated (CD90 FITC) (ab11155, abcam, UK) (specific
antigens for epithelial cells and fibroblasts, respectively) were incubated with the HECECs for
one hour each, at room temperature and the cells were counterstained with DAPI. Images
were taken with an automated inverted microscope Leica DMI 4000B, Leica DFC300FX cam-
era and pictures were analysed with Leica Microsystem LAS AF-AF6000 software.
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2.7 Functional studies
2.7.1 Hormonal preparation. 17-β-estradiol (E2) (E2758, Sigma) was dissolved in abso-
lute (100%) ethanol and MEM to the concentration of 20 μg/ml, as instructed by the manufac-
turer. Further dilutions were made in the MEM without Phenol Red to achieve the final
working concentrations of E2 of 0.1 and 10 nM.
2.7.2 TLR2 and TLR4 Agonists. The primary or first passaged cultured HECECs were
exposed to Peptidoglycan (PGN from S. aureus, 77140, Sigma Aldrich) (50μg/ml) [29] or Lipo-
polysaccharide (100ng/ml) (LPS from E. coli; L-2654-1MG) [30] while being simultaneously
treated with E2 at two different concentrations (0.1 and 10 nM) for 10 minutes, two hours and
18 hours. Three to four days prior to the stimulation with agonists of TLR2 and TLR4, the
media were substituted with phenol red-free MEM (51200, Gibco) supplemented with 10%
charcoal dextran-treated FBS, 0.2 mM L-glutamine and antibiotics (as mentioned in 2.3).
Hydrocortisone was not added in order to avoid its estrogenic effects [29,30]. MD-2, CD14
and LPS-binding protein (LBP) were added, as they are required for optimal cellular responses
to LPS [31]. These co-factors were provided with the necessary concentrations in the EGM for
the LPS stimulation experiments; Recombinant Human LBP (rhLBP; 870-LP-025 R&D sys-
tem) 1μg/ml [30], rhMD-2 (1787-MD R&D system) 2 ng/ml [32,33] and rhCD14 (383-CD,
R&D system) 0.07 μg/ml [30].
2.7.3 Evaluation of the expression of TLR2 and TLR4 by flow cytometry. Expression of
TLR2 and TLR4 in the cultured HECECs were evaluated by flow cytometry using Allophyco-
cyanin (APC) conjugated anti-human TLR2 (abcam, Cat. No. ab24996, IgG2a) and FITC
conjugated anti-human TLR4 Ab (abcam, Cat. No. ab45126, IgG2b). APC conjugated rat
IgG2a (eBioscience, Cat. No. 17-4724-41) and FITC conjugated rat IgG2b Isotype controls
(eBioscience, Cat. No. 11-4732-41) were supplied by eBioscience. Stain Buffer (FBS, BD Phar-
mingen Cat. No. 554656) was provided by BD Pharmingen. The HECECs were prepared
according to the suggested protocol from BD Pharmingen. Briefly, the cells were washed twice
in pre-warmed PBS without Ca2+ & Mg2+ (Sigma, Cat. No. D8537) then incubated with 5ml
pre-warmed CDSNE (C5914, Sigma, UK) for seven minutes at 37˚C. The cells were collected
in 15ml cone shaped tubes (Greiner centrifuge tubes T1818-500EA, Sigma) after detachment
and 7.5ml EGM was added to each tube to deactivate CDSNE. The mixture was split into two
tubes; one for gene expression study and the other for the TLRs study. The pellet was collected
using 500μl of ice-cold FBS and transferred to a flow cytometry tube (ELKay Autotubes, non-
sterile 1.1ml, 000-MICR-200) after centrifuging at 400 x g at 4˚C for 5 min. Single cell suspen-
sion was prepared and washed twice using ice cold FBS and spun at 400 x g for 5 min. The pel-
let was re-suspended in 50 μl FBS and the sample was stained with 5μl APC conjugated anti-
human TLR2 and 5 μl FITC conjugated anti-human TLR4 Ab. Equal volumes of APC conju-
gated rat IgG2a and FITC conjugated rat IgG2b Isotype controls were added to the corre-
sponding Isotype Control sample. The samples were incubated for 30 minutes on ice protected
from light. The cells were washed twice using 1 ml FBS to remove unbound antibodies. The
cell pellets were re-suspended in 500 μl FBS after spinning down at 400 x g for 5 min and the
samples were taken for cytometric evaluation within half an hour. Each set of experiments,
contained 5 to 7 samples, an isotype and an unstained control each time.
2.8 Total RNA extraction and RT-PCR
Total RNA extraction was performed from cultured HECECs using TRI Reagent (T9424,
Sigma), based on the manufacturer’s instructions. Chloroform was substituted with 1-Bromo-
3-chloropropane (BCP) (B9673, Sigma) for RNA extraction to reduce the possibility of DNA
contamination [34]. The eluted RNA was treated with rDNase I (Ambion1 DNA-free™ DNase
Estradiol effects on TLR-2 and -4 in cervical epithelium
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kit, AM1906) to remove the contaminating DNA. Quantification and quality controls of the
eluted RNA was carried out using the NanoDropTM 1000 Spectrophotometer (Thermo scien-
tific) and Agilent 2100 Bioanalyser (Agilent technologies, USA) respectively. 400 ng of the
eluted RNA from each sample was used for the first-strand cDNA synthesis using iScript
cDNA synthesis kit (170–8890, Bio-Rad), based on the manufacturer’s instructions. RT-PCR
was performed using the prepared cDNA; TLR2, TLR4, Estrogen Receptor α (ERα), ERβ,
membrane Progesterone Receptor α (mPRα), mPRβ, mPRγ and nuclear progesterone recep-
tors (nPRA & nPRB) forward and reverse primers (Table 1) and PCR Master mix, 2x (M750B,
Promega Madison, USA) as described before for TLRs [35], ERs [36] and PRs [37]. All the
experiments included a β-actin (positive control), a negative control with no cDNA and a No-
RT control in which reverse transcriptase enzyme (RT) was excluded at the stage of cDNA syn-
thesis. PCR products and the calibrator ladder (LowRanger DNA calibrator ladder, Cat. No.
11500, Norgen) were then resolved (10μl of each sample) through 1.2% agarose gels, and elec-
trophoresis was run with 1x TAE buffer (Tris-acetate and EDTA) at 45V for 2.5 hours. Agarose
gels were examined under a trans-illuminator and ethidium bromide (ETBr)/UV in a chemi-
HR16 (LFB) G:box syngene imaging system (Syngene, UK) and digital images were taken with
a GeneSnap 4.00.00 software (Synoptics Ltd).
2.9 Cytometric bead array
The Cytometric Bead Array technique was employed to measure eight cytokines [38] (IL-1β,
IL-6, IL-8, IL-10, IL-12p70, IFNγ, RANTES and TNF) in the collected supernatant at the study
time points of 10 minutes, 2hours and 18hours, to determine how E2 concentrations affected
the responses of the cultured HECECs to stimulation with TLR2 or TLR4 ligands. Each set of
experiments consisted of five samples and the baseline cytokine expression levels were deter-
mined from the supernatant fluid of HECECs stimulated with just the relevant TLR ligand.
Additionally, cytokine expression profiles of non-treated HECECs were used as control. Mas-
ter Buffer Kit (558264, The BD™ CBA Human Soluble Protein Flex Set System, BD Biosciences)
Table 1. Sequence of primers for TLR2, TLR4, ERα, ERβ, mPRα, mPRβ, mPRγ, nPRA&B and β-actin.
Gene primers 5´- 3´ Annealing Temp Product size
TLR2 Forward TCGGAGTTCTCCCAGTTCTCT 59.8˚C 175
Reverse TCCAGTGCTTCAACCCACAA 57.3˚C
TLR4 Forward CAACAAAGGTGGGAATGCTT 55.3˚C 317
Reverse TGCCATTGAAAGCAACTCTG
ER α Forward GAATCTGCCAAGGAGACTCG 59.4˚C 288
Reverse ATCTCTCTGGCGCTTGTGTT 57.3˚C
ER β Forward CCAGCAATGTCACTAACTTGGA 58.4˚C 217
Reverse TTCCCACTAACCTTCCTTTTCA 56.5˚C
mPRα Forward CCTGCTGTGTGATCTTAG 53.7˚C 288
Reverse CGGAAATAGAAGCGCCA 56.0˚C
mPRβ Forward CACGAAGGACCCACAAAACT 57.3˚C 232
Reverse CAATCCCAAGCACCACCTAT
mPRγ Forward AGCCCCTGGACGCTTTGA 58.2˚C 276
Reverse GGTCTGAGTCATGTTTCT 51.4˚C
nPR A&B Forward GCTACGAAGTCAAACCCAGT 57.3˚C 274
Reverse CACCATCCCTGCCAATATC 56.7˚C
β-Actin Forward AGCATTGCTTTCGTGTAAATTATGT 56.4˚C 207
Reverse TGGTCTCAAGTCAGTGTACAGGTAA 61.3˚C
https://doi.org/10.1371/journal.pone.0173646.t001
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was used for these assays and the samples were run on the BD FACS Array flow cytometry
machine, using FACP Array software.
2.10 Statistics
Data were collected and analysed using GraphPad Prism Version 6.0f. Brown Forsythe and
Bartlett’s analyses were first used to test for normality of the data. ANOVA model and Tukey’s
multiple comparison tests were used for the statistics. Differences were considered statistically
significant at p-value less than 0.05.
3. Results
Cultures of HECECs were successfully established for all the samples (S1 Fig). The epithelial
phenotype of the cultured cells was confirmed by double immunofluorescence sequential
staining to detect cytokeratin (CK). The exclusion of fibroblasts from the cultures was con-
firmed by the absence of staining to CD90 (Fig 1A).
The gene expression of TLR2, TLR4, ERα, ERβ, mPRα, mPRβ, mPRγ, nPRA and nPRB
were demonstrated by RT-PCR. All the amplified products were at the predicted size for the
relevant genes. No signals were detected for negative control samples, indicative of absence of
DNA contamination (Fig 2). The expression of ER and PR have been confirmed in previous
reports [39,40].
The expression of TLR2 and TLR4 was successfully and consistently demonstrated in the
cultured HECECs using flow cytometry (Fig 3).
3.1 Presence of E2 is associated with changes in the expression of
cytokines when TLR2 and TLR4 signalling pathways are activated in
cultured HECECs
3.1.1 HECECs stimulated with PGN in the presence of E2 (Fig 4). Estradiol did not have
a consistent effect on basal release of most cytokines studied: compared to control, expression
Fig 1. Cultured HECECs and validating their epithelial nature. (A & B) Double Immuno-Fluorescence sequential staining for HECECs and
HNFF; In “A and B” both antibodies (CK and CD90) and DAPI were used. The detected red signal from the HECECs (A) demonstrates that just the
Cytokeratine Ab (PE) was picked up. In “B” detected green signal represents specific Fibroblasts’ antigens identification. The nuclei have been
stained with DAPI, validating the cells were alive before fixation. No green signal was detected from the cytoplasm of the culture HECECs (A);
indicative of the absence of fibroblasts. HNFF; Human Neonatal Foreskin Fibroblast.
https://doi.org/10.1371/journal.pone.0173646.g001
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Fig 2. RT-PCR using RNA extracted from Cultured HECECs to investigate TLR2, TLR4, ERs and PRs gene expression. A:
Detection of the signals produced by RT-PCR products for β-Actin, TLR2 and TLR4. B: Depicts detection of ERα. C: Depicts detection
of ERβ. D: Signals were detected for mPRα, mPRβ, mPRγ and nPR A&B which represent the gene expression of these five receptors
while the detected signals for PRγ are much weaker than the others. No signal was detected in the negative controls, representing the
accuracy of the results. Presence of a faint band could be expected in the No-RT controls and it does not interfere with the accuracy of
the results.
https://doi.org/10.1371/journal.pone.0173646.g002
Fig 3. Flow cytometry results for the study of TLR2 and TLR4 expression in HECECs. A; TLR2
expression level in HECECs was revealed by detection of fluorochrome signals in histograms; Overlay
histograms of isotype control (Red) and an unknown sample (Blue) stained with APC conjugated human TLR2
Ab. The fluorochrome-stained HECECs for TLR2 were highlighted within the interval gate. These defined
gates were used to acquire the corresponding statistics. B; TLR4 expression level in the HECECs was
revealed by detection of fluorochrome signals in histograms; Overlay histograms of isotype control (Red),
unstained HECECs and an unknown sample (Brown) stained with FITC conjugated human TLR4 Ab. The
fluorochrome-stained HECECs for TLR4 were highlighted within the interval gate.
https://doi.org/10.1371/journal.pone.0173646.g003
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Fig 4. Detected cytokine secretion profiles when the cultured HECECs were stimulated with TLR2
agonist. Demonstrates significant changes in five out of eight studied cytokines when the HECECs were
Estradiol effects on TLR-2 and -4 in cervical epithelium
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levels of IL-1ß, IL-6, IL-10, IFNγ and RANTES were largely unchanged but the basal expres-
sion levels of IL-8 were suppressed. PGN stimulated the secretion of IL-1ß, IL-6, IL-8, IFNγ,
and RANTES, mostly after 18h of co-incubation. However, PGN did not appear to stimulate
IL-10 secretion by HECECS. With PGN stimulation the HECECs exposed to E2 released sig-
nificantly less IL-1β, IL-6 (18h) and IFNγ, and significantly more IL-8 (10min and 2h), IL-6
(10min and 2h) and RANTES (10min, 2h and 18h), than non-E2 treated controls.
3.1.2 HECECs stimulated with LPS in the presence of E2 (Fig 5). During these experi-
ments estradiol did not have a consistent effect on basal release of most cytokines studied:
compared to control, expression levels of all cytokines by untreated HECECs varied markedly
at all time points studied, with RANTES being consistently suppressed or unchanged. LPS
stimulated the sustained secretion of IL-6, IL-8, and RANTES by untreated HECECS and had
minimal or no effects on the expression levels of the other cytokines studied. Compared to
non-E2 treated controls, LPS stimulation of HECECs treated with E2 induced increased
amounts of IL-1β after 18h. Decreased secretion of RANTES was observed with E2 treatment
after 10 min, 2 and 18h. Conversely, IFNγ was decreased after 10min followed by enhanced
expression levels at 18h.
4. Discussion
We have demonstrated that E2 alters the cytokine responses of cultured HECECs when TLR2
and TLR4 signalling pathways are activated. However, the nature of the altered response varies
by cytokine and the duration of coincubation of HECECs with E2 and TLRs ligand. Whilst E2
appears to reduce the release of three of the eight cytokines measured (IL-1β, IL-6, IFNγ)
when TLR2 is stimulated by PGN, it enhances the release of the same cytokines as well as IL-8
when the TLR4 receptor is activated by LPS. Whilst the TLR2 ligand, PGN induces enhanced
expression levels of RANTES in the presence of E2, LPS suppresses RANTES from E2-exposed
HECECs. Our observations suggest that E2 modulates the immune responsiveness of cultured
primary HECECs exposed to exogenous ligands of TLR2 and TLR4 in a complex and varied
fashion.
In order to assess the immune-responsiveness of HECECs, we have studied their cytokine
expression response to ligand stimulation of the TLR2 and TLR4 pattern recognition recep-
tors, which respond to gram-positive and gram-negative bacteria, respectively. Some of these
pathogens cause sepsis of the female reproductive tract [41]. Inflammatory responses may be
promoted by stimulation of either endogenous or exogenous ligands of TLR2 and or TLR4.
We aimed to determine whether E2, a hormone that crucially drives the changes in the female
reproductive tract during the menstrual cycle as well as during pregnancy, alters the immune-
responsiveness of cervical epithelium. It has been observed that E2 can attenuate inflammation
at different physiological or supra-physiological levels, appearing to generally promote pro-
inflammatory pathways at lower physiologic levels [42]. Having established that PGN and LPS
increased expression levels of different cytokines by HECECs, we demonstrated that these
responses were significantly altered by co-incubation of HECECs with E2. The observed effects
varied with the duration of cell exposure to E2, suggesting that the effects observed after 10
min of E2 exposure could have a different underlying signalling mechanism to those observed
after 2 or 18h.
It has been recognised that there are multifaceted mechanisms involved with estrogen
receptor (ER) biological signalling [43]. More than four ER pathways have been described.
stimulated with PGN in the presence of two different concentrations of E2 compared to non-E2-treated. *p
value <0.05, **p value<0.005, ***p value<0.0005, ****p value<0.0001.
https://doi.org/10.1371/journal.pone.0173646.g004
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These include: a) the classical ligand-dependent pathway that involves E2-ER complexes bind-
ing to estrogen response elements (ERE) in target promoters leading to an up- or down-regu-
lation of gene transcription and subsequent tissue responses; b) the ligand-independent
pathways through which growth factors (GF) or cyclic AMP activate intracellular kinase path-
ways, leading to phosphorylation and activation of ER in a ligand-independent manner; and c)
the ERE-independent signalling that involves E2-ER complexes altering transcription of genes
through association with other DNA-bound transcription factors that tether the activated ER
to DNA, resulting in an up-regulation of gene expression. Finally, it has long been recognised
that cell-surface (non-genomic) E2 signalling occurs by the activation of a putative membrane-
associated binding site, possibly a form of ER linked to intracellular signal transduction path-
ways that generate rapid tissue responses. It is unclear which of these pathways is involved in
our observations, but it is highly likely that the effects of E2 on TLR2- and TLR4-mediated
ligand activity in HECECs noted after 10 min are membrane-associated non-genomic effects
[44,45], whilst other nuclear genomic pathways are likely to mediate the sustained cytokine
responses noted after 2 to 18 h. Interestingly, the effects of E2 on LPS-induced cytokine expres-
sion profiles by HECECs are remarkably similar at 2 and 18 h but often dissimilar or opposite
to observations after 10 min during the same experiments.
The binding of E2 to the ER initiates the relevant ligand-dependent E2 signalling. The subse-
quent cell-specific transcriptional response to E2 is determined by multiple factors; the compo-
sition of co-regulatory proteins in a given cell and the characteristics of the promoters of
estrogen responsive genes are the most important factors. Since hormones are modulators of
transcription, the pattern of modulated genes also depends on what other signalling pathways
are active in the cell at the time of hormone exposure [46,47]. This may explain how E2 can dif-
ferentially modify immune responses of HECECs when either TLR2 or TLR4 downstream sig-
nalling pathways is activated.
Substantial signalling complexity, consistent with our observations, is suggested by reports
that individual cytokine responses to ligand-mediated immune cell activation can vary greatly
with tissue and duration of stimulation [48]. Such complexity has led to the investigation of
cytokine profiles in various disease and physiological states in an attempt to define cytokine
“signatures” that facilitate disease diagnosis, assessment of associated morbidity, and for moni-
toring therapy. Distinctive disease-specific cytokine profiles have been identified in inflamma-
tory bowel disease and have been demonstrated to show significant correlations to disease
activity and duration [49]. Whether the changes in cytokine expression that we have described
reflect consistent E2-induced gestational changes required to combat infection and modulate
inflammation remains to be investigated. It is plausible that PAMPs, DAMPs and gestational
hormones may drive the changes in cytokine expression profiles by cervical epithelial cells
required to combat sepsis or influence cervical remodelling preparatory to birth [11]. These in
vivo gestational changes in immune-responsiveness of cervical epithelial cells are likely to be
more complex than we have observed in our experiments because several other hormones
(such as progesterone) and tissue factors are likely to play significant roles.
Our observations suggest that cytokine expression profiles are likely to be altered during
human pregnancy under hormonal influence, compared to the nonpregnant state. However,
the nature of such change and its physiological relevance remains to be determined. Studies
have highlighted the potential pathogenic role for these changes in the aetiology of preterm
Fig 5. Detected cytokine secretion profiles when the cultured HECECs were stimulated with TLR4
agonist. Depicts significant alteration in five out of eight studied cytokine levels when the HECECs were
stimulated with LPS in the presence of two different E2 concentrations compared to non-E2-treated HECECs.
*p value <0.05, **p value<0.005, ***p value<0.0005, ****p value<0.0001.
https://doi.org/10.1371/journal.pone.0173646.g005
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birth. One study noted that a higher proportion of women with low levels of IL-1α (below 25th
percentile) delivered preterm compared to women with higher IL-1α levels, suggesting that
the rate of preterm delivery increased when IL-1α levels decreased [50]. Another study also
demonstrated that women in the lowest quartile of cervical concentrations of IL-1β and IL-8
early in pregnancy were significantly more likely to subsequently experience chorioamnionitis
than women in higher quartiles. We observed sustained increased expression of IL-1ß, IL-8
and IFNγ by HECECs stimulated with LPS in the presence of E2: this could represent an
immunoprotective effect conferred on these cells by E2, thus providing protection of the con-
ceptus against ascending infection and perhaps preventing inflammation-induced preterm
birth. In contrast, we observed that E2 appears to predominantly reduce pro-inflammatory
cytokine expression of HECECs to PGN, TLR2 ligand. The reason for this observation is
unclear. It may reflect an anti-inflammatory response of HECECs to those bacterial ligands
that would otherwise induce inappropriate inflammation in the lower reproductive tract.
Whether this process may be accentuated during pregnancy to confer additional protection
against infection to the conceptus remains to be determined. Estradiol also appears to suppress
the release of RANTES, a chemotactic cytokine, by HECECs exposed to LPS whilst increasing
RANTES release by HECECs exposed to PGN, suggesting a ligand-specific modulatory effect
of estradiol on HECECs.
There is a paucity of studies investigating commensal-host immunologic interactions in the
female reproductive tracts. However insight into TLR-commensal interactions is gleaned from
studies of the gut where it has been demonstrated that the microbial ligands recognized by
TLRs are not unique to pathogens, being also produced by commensal microorganisms [51].
These studies have demonstrated several mechanisms by which intestinal epithelial immuno-
logical homeostasis is maintained despite exposure to commensals and pathogens. Firstly,
surface epithelium may sequester bacteria on contact thereby avoiding mounting an inflam-
matory response. Secondly, commensal microflora may activate TLRs in a way that prevents
tissue injury and associated mortality [51]. One such mechanism could be the paradoxic
reduction in cytokine production by epithelial cells when exposed to PAMPs from commen-
sals rather than pathogens. This may explain our observations in regard to PGN. Overall, the
varied cytokine responses of E2-treated cervical epithelial tissue to TLR2 and TLR4 ligands,
suggest complex host-microbial interactions required by tissues that are exposed to both com-
mensal and pathogenic florae.
In addition to their role in host defence against infections, these cytokines may also modu-
late cervical remodelling of sub-epithelial cervical matrix during pregnancy, perhaps by in-
ducing chemokines and local tissue infiltration by white cells. They may also cause vascular
changes that induce matrix breakdown and alter tissue hydration [11]. The pattern of cytokine
expression under the influence of E2, may change the polarisation of the immune responses
from a Th2 to a Th1 type. Activation of Th1-type immune responses can initiate the final
rapid stage of softening of the uterine cervix by inducing neutrophil infiltration and increasing
the activity of proteases such as collagenase and elastase, and prostaglandins [11]
Our in vitro studies of E2 on isolated cervical epithelial cells have several limitations. Whilst
it enables characterisation of the modulatory role of E2 on the immune-responsiveness of these
cells, it does not take into account the associated, rather more complex, influence of other ges-
tational hormones such as progesterone on the immune-responsiveness of this reproductive
tract epithelium [52,53]. Furthermore the precise role of endogenous ligands of TLRs and
DAMPs, believed to play key role(s) in receptor activation and the pathogenesis of preterm
birth [11,12] require further studies. It is likely that E2 and the innate immune system maintain
an active interaction during normal pregnancy even without exogenous PAMPs. Understand-
ing the mediators of such interaction would shed further light on the observed difference
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between the effects of TLR2 and TLR4 ligands on cytokines in the presence of E2, as well as the
mechanisms of cervical tissue remodeling associated with premature birth.
In conclusion, HECECs cultured in the presence of E2 demonstrate altered cytokine expres-
sion profiles in response to TLR2 and TLR4 ligands. The varied nature and time course of
these changes suggest a complex immune-modulatory role for E2 at this epithelial surface.
Such a role would enable the mucosa of the lower reproductive tract discriminate between
commensals and pathogens, and mount appropriate host defence against ascending infection
in the pregnant and non-pregnant state. The signalling mechanisms for these observations
remain to be elucidated.
Supporting information
S1 Fig. Culturing HECECs from digested diced tissue. (A&B); Pieces of tissue (Ectocervix)
with growing HECECs have been shown. “e”; Explant, “g”; Growing HECECs.
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